Thrombopoietic agents are drugs that induce the growth and maturation of megakaryocytes.[1] Some of them are currently in clinical use: romiplostim,[2] eltrombopag, oprelvekin (a recombinant interleukin 11) and thrombopoietin. Several others are under clinical investigation such as lusutrombopag and avatrombopag.

References

  1. ↑ Michael Clinton Perry. The Chemotherapy Source Book. Lippincott Williams & Wilkins, 2008 pg. 51
  2. ↑ Romiplostim


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.